kabutan

Medical Data Vision Co.,Ltd.(3902) Summary

3902
TSE Prime
Medical Data Vision Co.,Ltd.
1,680
JPY
-2
(-0.12%)
Feb 10, 3:30 pm JST
10.81
USD
Feb 10, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
20.7
Yield
ー%
Margin Trading Ratio
9.86
Stock Price
Feb 10, 2026
Opening Feb 10, 9:00 am
1,681 JPY 10.76 USD
Previous Close Feb 9
1,682 JPY 10.75 USD
High Feb 10, 9:00 am
1,681 JPY 10.83 USD
Low Feb 10, 9:27 am
1,678 JPY 10.73 USD
Volume
174,000
Trading Value
0.29B JPY 1.88M USD
VWAP
1679.75 JPY 10.81 USD
Minimum Trading Value
168,000 JPY 1,081 USD
Market Cap
0.07T JPY 0.43B USD
Number of Trades
282
Liquidity & Number of Trades
As of Feb 10, 2026
Liquidity
Slightly High
1-Year Average
415
1-Year High Dec 18, 2025
3,108
Margin Trading
Date Short Interest Long Margin Positions Ratio
Feb 6, 2026 8,400 32,200 3.83
Jan 30, 2026 13,300 30,300 2.28
Jan 23, 2026 19,300 31,400 1.63
Jan 16, 2026 17,000 106,600 6.27
Jan 9, 2026 17,000 216,700 12.75
Company Profile
Medical Data Vision Co., Ltd. provides a "Data Network" for hospital and medical information, as well as data utilization services of medical information for pharmaceutical companies.
Sector
Information & Communication
Medical Data Vision Co., Ltd. offers management support systems for hospitals and clinics while simultaneously collecting and storing medical and health information with consent from medical institutions and patients. By analyzing and utilizing this data, the company contributes to improving the quality of healthcare. Their main services include "MDV Act," a cloud-based hospital management improvement application; "EVE," a DPC (Diagnosis Procedure Combination) analysis benchmark system; and "Medical Code," a management issue resolution support system. Through the provision of these systems, the company has built a hospital network, which forms the basis for constructing a large-scale medical database. Utilizing this database, Medical Data Vision offers "MDV analyzer," a drug prescription analysis tool, and ad hoc survey services for pharmaceutical companies and research institutions. Additionally, the company has developed "Karteco," a PHR (Personal Health Record) service for patients.